Company Green Cross Medical Science Corporation

Equities

A142280

KR7142280007

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
4,085 ^KRW	+0.12%		+0.49%	-14.36%

2023	Green Cross Medical Science Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	Green Cross Medical Science Corporation announced that it has received KRW 30 billion in funding from Daishin Securities Co. Ltd., Investment Arm and other investors	CI

Green Cross Medical Science Corporation is a Korea-based company principally engaged in the medical business. The Company mainly operates its business through three segments: diagnosis reagent segment, blood bag segment and blood dialysate segment. Its diagnosis reagent segment provides in vitro diagnosis reagents and medical equipment. Its blood bag segment provides filter bags and blood bags. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 131

KRW in Million	2022	Weight	2023	Weight	Delta
Green Cross MS 100.1 %	110,820	98.0 %	94,066	100.1 %	-15.12%
Connection Adjustment -12.6 %	-12,595	-11.1 %	-11,811	-12.6 %	-6.23%
Green Cross Medis 12.5 %	14,884	13.2 %	11,756	12.5 %	-21.02%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 93.6 %	101,113	89.4 %	87,993	93.6 %	-12.98%
Overseas 6.4 %	11,996	10.6 %	6,018	6.4 %	-49.83%

Managers	Title	Age	Since
Yu-Shin Kim BRD	Director/Board Member	59	-
Sang-Soon Hwang AUD	Comptroller/Controller/Auditor	70	-

Members of the board	Title	Age	Since
Jeong-Han Song BRD	Director/Board Member	61	19-03-26
Yu-Shin Kim BRD	Director/Board Member	59	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	21,136,211	9,873,644 ( 46.71 %)	35,000 ( 0.1656 %)	46.71 %

Name	Equities	%	Valuation
GC BIOPHARMA CORP. 41.47 %	8,765,704	41.47 %	29 M ₩
Il-Sup Huh 10.38 %	2,193,520	10.38 %	7 M ₩
Jung-mi Huh 0.3931 %	83,088	0.3931 %	273 103 ₩
Gi-joon Huh 0.3520 %	74,400	0.3520 %	244 546 ₩
Gi-Soo Huh 0.3520 %	74,400	0.3520 %	244 546 ₩
GREEN CROSS MEDICAL SCIENCE CORPORATION 0.1656 %	35,000	0.1656 %	115 042 ₩
Young-Hee Sagong 0.1419 %	30,000	0.1419 %	98 607 ₩
Yong-Tae Park 0.1139 %	24,082	0.1139 %	79 155 ₩

Name	Equities	%	Valuation
GREEN CROSS MEDICAL SCIENCE CORPORATION 0.17%	35,000	0.17%	115,042 $

Green Cross Medical Science Corp.

2/F, 15 Yonggu-daero 2469 beon-gil Giheung-gu

16907, Yongin-si

http://www.greencrossms.com

address Green Cross Medical Science Corporation(A142280)

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
GREEN CROSS MEDICAL SCIENCE CORPORATION	-14.36%	62.94M
BIOMÉRIEUX	-1.29%	12.64B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-0.47%	8.46B
DIASORIN S.P.A.	+5.68%	5.66B
LANTHEUS HOLDINGS, INC.	+22.61%	5.27B
AUTOBIO DIAGNOSTICS CO., LTD.	-2.03%	4.49B
10X GENOMICS, INC.	-53.56%	3.11B
ANDON HEALTH CO., LTD.	+19.30%	2.87B
MYRIAD GENETICS, INC.	+33.07%	2.31B
VITROLIFE AB	-8.42%	2.23B

Diagnostic & Testing Substances